Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 2,895 | 8,470 | 3,176 | 2,022 | 2,874 |
| Cost of Goods | 144 | 677 | 125 | 22 | 141 |
| Gross Profit | 2,751 | 7,793 | 3,051 | 2,000 | 2,733 |
| Operating Expenses | 18,259 | 14,722 | 16,007 | 11,335 | 9,500 |
| Operating Income | -15,364 | -6,252 | -12,831 | -9,313 | -6,626 |
| Interest Expense | 366 | 197 | 182 | 170 | 124 |
| Other Income | 5,540 | 3,802 | -307 | 15,952 | 101 |
| Pre-tax Income | -10,190 | -2,647 | -13,320 | 6,469 | -6,649 |
| Income Tax | 177 | -74 | -103 | 719 | -33 |
| Net Income Continuous | -10,367 | -2,573 | -13,217 | 5,750 | -6,616 |
| Net Income | $-10,367 | $-2,573 | $-13,217 | $5,750 | $-6,616 |
| EPS Basic Total Ops | -0.30 | -0.08 | -0.38 | 0.16 | -0.19 |
| EPS Basic Continuous Ops | -0.30 | -0.08 | -0.38 | 0.17 | -0.19 |
| EPS Diluted Total Ops | -0.30 | -0.08 | -0.38 | 0.16 | -0.19 |
| EPS Diluted Continuous Ops | -0.30 | -0.08 | -0.38 | 0.17 | -0.19 |
| EBITDA(a) | $-15,302 | $-6,174 | $-12,752 | $-9,013 | $-6,228 |